1. A cordless instrumental system, in which a cordless instrument detachable from a charger is charged by attaching to said charger, comprising:
a first storage part chargeable from a direct current source included in said charger;
a first charge and discharge control circuit to control charge and discharge of said first storage part;
a second storage part included in said cordless instrument; and
a second charge and discharge control circuit to control charge and discharge of said second storage part;
and is capable of charging at least from said first storage part to said second storage part upon attaching said cordless instrument.
2. The cordless instrumental system as set forth in claim 1, characterized in that said first and second storage parts are constituted with an electric double-layer capacitor or an electrochemical capacitor.
3. The cordless instrumental system as set forth in claim 1 or 2, characterized in that said second storage part is chargeable from said first storage part or said direct current source.
4. The cordless instrumental system as set forth in claim 3, characterized in that the charging route to said second storage part is switched to either said first storage part or said direct current source depending upon the charge output of said first storage part.
5. The cordless instrumental system as set forth in claim 1, characterized in that said second charge and discharge control circuit is included either in said cordless instrument or in said charger.
6. The cordless instrumental system as set forth in claim 1 or 2, characterized in that a plurality of said first storage parts are parallelly connected to said direct current source.
7. A cordless instrumental system in which a cordless instrument detachable from a charger is charged by attaching to said charger, comprising:
a first storage part chargeable from a direct current source included in said charger;
a third storage part chargeable from the direct current source, and chargeable to said first storage part;
a first charge and discharge control circuit to control charge and discharge of said first and third storage parts;
a second storage part included in said cordless instrument; and
a second charge and discharge control circuit to control charge and discharge of said second storage part;
and is capable of charging at least from said first storage part to said second storage part upon attaching said cordless instrument.
8. The cordless instrumental system as set forth in claim 7, characterized in that said first and second storage parts are constituted with an electric double-layer capacitor or an electrochemical capacitor.
9. The cordless instrumental system as set forth in claim 7, characterized in that said third storage part is constituted with a chargeable battery.
10. (canceled)
11. The cordless instrumental system as set forth in claim 7 or 8, characterized in that said second storage part is chargeable from said first storage part or said direct current source.
12. The cordless instrumental system as set forth in claim 7 or 8, characterized in that the charging route to said second storage part is switched to said first storage part or to said direct current source depending upon the charge output of said first storage part.
13. (canceled)
14. The cordless instrumental system as set forth in claim 7 or 8, characterized in that a plurality of said first storage parts are parallelly connected to said direct current source.
15. A cordless instrumental system, in which a cordless instrument detachable from a charger including a direct current source is attached to said charger and is charged, comprising:
a first and the third storage parts chargeable from said direct current source, and provided in said charger;
a second and the fourth storage parts included in said cordless instrument;
a charge and discharge control circuit to control charge and discharge of said first to fourth storage parts; and
a discharge control circuit to control discharge of said second and fourth storage parts;
and is capable of charging at least from said first and third storage parts to said second storage part, as well as of charging from said third storage part to said fourth storage part, upon attaching said cordless instrument.
16. The cordless instrumental system as set forth in claim 15, characterized in that said first and second storage parts are constituted with an electric double-layer capacitor or an electrochemical capacitor.
17. The cordless instrumental system as set forth in claim 15, characterized in that said third and fourth storage parts are constituted with a battery.
18. The cordless instrumental system as set forth in claim 15 or 16, characterized in that said second storage part is chargeable from either of said first or third storage parts, or from the combination thereof.
19. The cordless instrumental system as set forth in claim 15 or 17, characterized in that said fourth storage part is chargeable from said third storage part.
20. The cordless instrumental system as set forth in claim 15, characterized in that said discharge control circuit to control discharge of the second and the fourth storage parts is included in said cordless instrument.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. An isolated nucleic acid molecule comprising a polynucleotide having a nucleotide sequence at least 95% identical to a sequence selected from the group consisting of:
(a) a polynucleotide fragment of SEQ ID NO:X or a polynucleotide fragment of the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X;
(b) a polynucleotide encoding a polypeptide fragment of SEQ ID NO:Y or a polypeptide fragment encoded by the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X;
(c) a polynucleotide encoding a polypeptide domain of SEQ ID NO:Y or a polypeptide domain encoded by the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X;
(d) a polynucleotide encoding a polypeptide epitope of SEQ ID NO:Y or a polypeptide epitope encoded by the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X;
(e) a polynucleotide encoding a polypeptide of SEQ ID NO:Y or the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X, having biological activity;
(f) a polynucleotide which is a variant of SEQ ID NO:X;
(g) a polynucleotide which is an allelic variant of SEQ ID NO:X;
(h) a polynucleotide which encodes a species homologue of the SEQ ID NO:Y;
(i) a polynucleotide capable of hybridizing under stringent conditions to any one of the polynucleotides specified in (a)-(h), wherein said polynucleotide does not hybridize under stringent conditions to a nucleic acid molecule having a nucleotide sequence of only A residues or of only T residues.
2. The isolated nucleic acid molecule of claim 1, wherein the polynucleotide fragment comprises a nucleotide sequence encoding a secreted protein.
3. The isolated nucleic acid molecule of claim 1, wherein the polynucleotide fragment comprises a nucleotide sequence encoding the sequence identified as SEQ ID NO:Y or the polypeptide encoded by the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X.
4. The isolated nucleic acid molecule of claim 1, wherein the polynucleotide fragment comprises the entire nucleotide sequence of SEQ ID NO:X or the cDNA sequence included in ATCC Deposit No:Z, which is hybridizable to SEQ ID NO:X.
5. The isolated nucleic acid molecule of claim 2, wherein the nucleotide sequence comprises sequential nucleotide deletions from either the C-terminus or the N-terminus.
6. The isolated nucleic acid molecule of claim 3, wherein the nucleotide sequence comprises sequential nucleotide deletions from either the C-terminus or the N-terminus.
7. A recombinant vector comprising the isolated nucleic acid molecule of claim 1.
8. A method of making a recombinant host cell comprising the isolated nucleic acid molecule of claim 1.
9. A recombinant host cell produced by the method of claim 8.
10. The recombinant host cell of claim 9 comprising vector sequences.
11. An isolated polypeptide comprising an amino acid sequence at least 95% identical to a sequence selected from the group consisting of:
(a) a polypeptide fragment of SEQ ID NO:Y or the encoded sequence included in ATCC Deposit No:Z;
(b) a polypeptide fragment of SEQ ID NO:Y or the encoded sequence included in ATCC Deposit No:Z, having biological activity;
(c) a polypeptide domain of SEQ ID NO:Y or the encoded sequence included in ATCC Deposit No:Z;
(d) a polypeptide epitope of SEQ ID NO:Y or the encoded sequence included in ATCC Deposit No:Z;
(e) a secreted form of SEQ ID NO:Y or the encoded sequence included in ATCC Deposit No:Z;
(f) a full length protein of SEQ ID NO:Y or the encoded sequence included in ATCC Deposit No:Z;
(g) a variant of SEQ ID NO:Y;
(h) an allelic variant of SEQ ID NO:Y; or
(i) a species homologue of the SEQ ID NO:Y.
12. The isolated polypeptide of claim 11, wherein the secreted form or the full length protein comprises sequential amino acid deletions from either the C-terminus or the N-terminus.
13. An isolated antibody that binds specifically to the isolated polypeptide of claim 11.
14. A recombinant host cell that expresses the isolated polypeptide of claim 11.
15. A method of making an isolated polypeptide comprising:
(a) culturing the recombinant host cell of claim 14 under conditions such that said polypeptide is expressed; and
(b) recovering said polypeptide.
16. The polypeptide produced by claim 15.
17. A method for preventing, treating, or ameliorating a medical condition, comprising administering to a mammalian subject a therapeutically effective amount of the polypeptide of claim 11 or the polynucleotide of claim 1.
18. A method of diagnosing a pathological condition or a susceptibility to a pathological condition in a subject comprising:
(a) determining the presence or absence of a mutation in the polynucleotide of claim 1; and
(b) diagnosing a pathological condition or a susceptibility to a pathological condition based on the presence or absence of said mutation.
19. A method of diagnosing a pathological condition or a susceptibility to a pathological condition in a subject comprising:
(a) determining the presence or amount of expression of the polypeptide of claim 11 in a biological sample; and
(b) diagnosing a pathological condition or a susceptibility to a pathological condition based on the presence or amount of expression of the polypeptide.
20. A method for identifying a binding partner to the polypeptide of claim 11 comprising:
(a) contacting the polypeptide of claim 11 with a binding partner; and
(b) determining whether the binding partner effects an activity of the polypeptide.
21. The gene corresponding to the cDNA sequence of SEQ ID NO:Y.
22. A method of identifying an activity in a biological assay, wherein the method comprises:
(a) expressing SEQ ID NO:X in a cell;
(b) isolating the supernatant;
(c) detecting an activity in a biological assay; and
(d) identifying the protein in the supernatant having the activity.
23. The product produced by the method of claim 20.